Bacterial TherapeuticsBacterial Therapeutics. A review of current scientific research, applications and resources.
Edited by: Kenji Sonomoto and Atsushi Yokota"cutting-edge" (Food Sci. Technol. Abstr); "high scientific quality and timeliness" (Biospektrum); "compact and excellent book" (Microbiol. Today); "written very clearly" (ASM Microbe) read more ...
Essential reading for every researcher working with LAB, bifidobacteria and probiotics, from the PhD student to the experienced scientist.
Bacterial TherapeuticsAdapted from Parks et al. in Probiotics and Prebiotics: Scientific Aspects
Bacterial Therapeutics: The microbiota of the healthy human vagina is dominated by Lactobacillus species, which play an important role in protecting the host from urogenital infections. Disruption of the Lactobacillus-dominated microbiota can lead to abnormal vaginal microbial communities associated with bacterial vaginosis, and an increased incidence of urinary tract infection (UTI). In addition, epidemiological studies suggest that the normal vaginal microbial ecosystem may play a critical role in reducing the risk of sexually transmitted infections, including human immunodeficiency virus type 1 (HIV-1). Chapter 8 of Probiotics and Prebiotics: Scientific Aspects focuses on the role of lactobacilli in the vaginal ecosystem and the rational use of these bacteria as therapeutic agents for the treatment and prevention of urogenital infections.
- Bacterial-Plant Interactions
- Metagenomics of the Microbial Nitrogen Cycle
- Pathogenic Neisseria
- Human Pathogenic Fungi
- Applied RNAi
- Molecular Diagnostics
- Phage Therapy
- Bioinformatics and Data Analysis in Microbiology
- The Cell Biology of Cyanobacteria
- Pathogenic Escherichia coli
- Campylobacter Ecology and Evolution
- Next-generation Sequencing
- Omics in Soil Science
- Applications of Molecular Microbiological Methods
- Genome Analysis
- Bacterial Toxins
- Bacterial Membranes
- Cold-Adapted Microorganisms